SkyePharma grants Japanese rights

U.K. drug delivery play SkyePharma (LSE:SKP; SKYE) has granted marketing and distribution rights for Japan and Taiwan to Nippon Shinyaku (Kyoto, Japan) for DepoCyt, an injectable, sustained release fo...